Wegovy Monitoring Blood Test
This blood test monitors kidney function, liver function, and lipid levels for individuals using Semaglutide for weight management, ensuring internal health and safety.
- The description claims high-dose GLP-1 therapy can sometimes lead to acute kidney injury.
- The description claims rapid burning of fat stores can affect liver function.
Variants (1)
- Default Title — 129.75 GBP — In stock
AI Readiness
Good foundation, but some important product data is still missing.
72%